Nepsis Inc. grew its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 55.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,742 shares of the medical research company’s stock after acquiring an additional 20,630 shares during the quarter. Amgen comprises […]